Facebook event page | Hashtags: #WorldDentalCongress & #FDI2017Madrid
cabecera

Antimicrobial resistance and antimicrobial stewardship in clinical dentistry science committee forum

Thomas Sollecito (USA)
Susan Sanderson (United Kingdom)
Céline Pulcini (France)
D. Findlay (United Kingdom)

Time: 15:00 - 17:30
Room: VELAZQUEZ (PV3)
Language: English
Chair(s): Thomas Hart (USA)
CERP: 2.5

Antimicrobial Resistance (AMR) is a serious threat to public health with the potential to affect people in every part  of the world. Bacteria can develop resistance to specific antibiotics, meaning that the antibiotic is no longer effective against those bacteria. Although antibiotic resistance is  a  natural  feature  of  bacterial  evolution,  the  inappropriate use of antibiotics has increased the development of antibiotic-resistant bacteria affecting all levels of clinical care. Antibiotics underpin routine clinical practice in most healthcare settings, including dentistry, and the emerging threat of AMR represents an economic and health threat of epic proportions. Therefore, the issues of AMR and antimicrobial stewardship (AMS) must be addressed now.

The purpose of this symposium is to overview the scope of the problem of AMR and inform dentists of the major issues related to AMR in medicine and dentistry. The symposium will discuss the need for effective AMS to reduce and prevent development of AMR. The symposium will also overview why it is difficult to develop new antibiotics, and discuss new approaches being developed to enable dentists and the public to fight microbial pathogens. The symposium is designed to inform and educate dentists and their staff of the main issues related to AMR and AMS so that they may develop practice modes that reduce development of AMR. This symposium is also designed to enable dentists to educate their patients and participate in local, national and international responses to reduce the development of AMR and support efforts to promote AMS.

ANTIMICROBIAL RESISTANCE: SCOPE OF THE PROBLEM
Thomas Sollecito (USA)

Learning Objectives

  • > To understand the diverse factors that contribute to AMR
  • > To appreciate that AMR is a serious medical threat to healthcare beyond dentistry
  • > To provide dentists and their staff with information to help understand the threat of AMR and to be able to educate their patients about the issues

Abstract

This session will overview the scope of the problem of AMR. Factors contributing to AMR include lax use of antibiotics   in agriculture, fisheries and human clinical care. The morbidity and mortality arising from AMR are rapidly increasing worldwide, and the estimated economical costs are staggering. As the roots of the AMR problem are multifaceted and reach worldwide, the ability to introduce strategies to reduce AMR will involve an understanding and strategies to counter these diverse contributing factors. For dentists to be an effective part of the response, they must understand the local, national and international issues involved. The interface of dental care and the greater medical healthcare arena will be discussed from the AMR and AMS perspective so that dentists can see the role and relationship of their clinical practice in the global perspective.

ANTIMICROBIAL RESISTANCE: THE DENTAL CLINICAL PERSPECTIVE
Susan Sanderson (United Kingdom)

Learning Objectives

  • > To understand the threat of AMR in the dental office
  • > To understand how AMR can affect the ability of dentists to render care to their patients
  • > To understand how dentists can reduce the development of AMR in their practice

Abstract

This presentation will overview issues related to AMR with a focus on the contributions and effects on the dental clinical practice. Dr. Sanderson will describe how the problem presents in the dental practice and how dental practice can contribute to the problem. She will also present basic principles for how dental practice can be more effective in implementing AMS approaches.

ANTIMICROBIAL STEWARDSHIP - EDUCATION, TRAINING, ACTION: WHAT CANYOU DOTO PROMOTE ANTIBIOTIC STEWARDSHIP AND REDUCE ANTIBIOTIC RESISTANCE
Céline Pulcini (France)

Learning Objectives

  • > To inform dentists of the issues related to AMR locally, nationally and internationally
  • > To educate dentists about how they can organize their clinical practice to conform to principles of AMS, properly use antibiotics and antimicrobial agents, and reduce development of AMR
  • > To educate dentists of the issues related to AMS so that they can act as effective stewards in their communities

Abstract

Dentists are in positions to reduce the development of AMR through effective AMS.  This  session  will  overview  issues  related to development of AMR, emphasizing contributions from clinical care settings. Studies have shown that antibiotic prescribing often does not conform to recommendations. Data will be presented showing how sub-optimal  or improper clinical management contributes to AMR. This will serve to outline the needs and define the tools necessary to ensure that health workers are educated and/or trained to the level of competence needed for effective AMS to limit AMR. Practical approaches include improved infection control practices and optimizing prescribing practice through implementation of AMS programmes. The need for better education of healthcare providers about appropriate antibiotic use will be discussed. The importance of gathering surveillance data so that effective stewardship programmes can be developed will also be discussed.

CHALLENGES AND INCENTIVES IN DEVELOPING NEW ANTIBIOTIC
D. Findlay (United Kingdom)

Learning Objectives

  • > To recognise the threat of a diminishing antibacterial pipeline
  • > To understand the major challenges in discovery and development of new antibacterials
  • > To understand global and local initiatives to increase antibacterial R&D   

Abstract

The presentation will address the challenges in bringing new antibiotics through the pipeline to approval and use. It addresses the ‘broken’ commercial model for antibacterial R&D and the resulting impact on investment in this key therapy area. The presentation will conclude with a review of initiatives to correct the ‘broken’ model and incentivise further investment in antibacterial R&D.

Next Event

FDI 2017
29 August - 1 Septembre 2017
Madrid, Spain

Technical Secretariat

logoGPBlanco  Marià Cubí, 4 | 08006 | Barcelona
  +34 932.388.777
  +34 932.387.488
  This email address is being protected from spambots. You need JavaScript enabled to view it.

Stay Connected on: